Special Issue "Obesity and Bariatric/Metabolic Surgery: Risks, Outcomes, Prognosis, and Development Trends"
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 8276
2. INSERM, Nutrition and Obesity: Systemic Approach (NutriOmics) Research Unit, Sorbonne Université, Paris, France
Interests: obesity; bariatric; complication; precision medicine; surgery; metabolic surgery
Bariatric practice is moving toward precision medicine and surgery. Recent advances in the understanding of the pathophysiology of obesity and associated metabolic diseases (e.g., type 2 diabetes, hypertension, dyslipidemia) have enabled the identification of implications in clinical features, the development of precise diagnostic methods or targeted therapy, and the accurate prediction of “metabolic prognosis” after weight loss intervention, including bariatric surgery (BS). BS provides long-term weight loss, and revisional surgery is increasingly being performed either in cases of insufficient weight loss or for chronic complications. While the safety profile of BS is constantly improving, efforts should be focused on identifying predicting factors and optimal treatments of severe postoperative morbidity and of metabolic response in primary and revisional settings to define the outcomes in all surgical situations. In addition, the fantastic improvement of metabolic features following surgery has demonstrated that the gastrointestinal tract is a key organ in metabolic regulation and, therefore, a rational target for interventions aimed at treating metabolic disorders (e.g., metabolic surgery). Several recent randomized clinical trials have demonstrated that bariatric/metabolic surgery causes greater improvement of type 2 diabetes and reduction in cardiovascular risk compared with lifestyle modification and medical therapies and regardless of weight loss at the long term, allowing a paradigm shift. With the recent COVID-19 pandemic, telemedicine is rapidly being applied to bariatric practice for optimal follow-up. All these discoveries have improved the clinicians’ approach to diagnosis, treatment, and the prediction of prognosis after weight loss interventions in different settings. The aim of this Special Issue is to highlight recent advances in the context of obesity and bariatric/metabolic surgery.
Dr. Laurent Genser
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.